[HTML][HTML] Obesity, type 2 diabetes, and cancer risk
T Scully, A Ettela, D LeRoith, EJ Gallagher - Frontiers in oncology, 2021 - frontiersin.org
Obesity and type 2 diabetes have both been associated with increased cancer risk and are
becoming increasingly prevalent. Metabolic abnormalities such as insulin resistance and …
becoming increasingly prevalent. Metabolic abnormalities such as insulin resistance and …
[HTML][HTML] Obesity, Type 2 Diabetes, and Cancer Risk
T Scully, A Ettela, D LeRoith, EJ Gallagher - Frontiers in Oncology, 2020 - ncbi.nlm.nih.gov
Obesity and type 2 diabetes have both been associated with increased cancer risk and are
becoming increasingly prevalent. Metabolic abnormalities such as insulin resistance and …
becoming increasingly prevalent. Metabolic abnormalities such as insulin resistance and …
[引用][C] Obesity, Type 2 Diabetes, and Cancer Risk
T Scully, A Ettela, D LeRoith… - Frontiers in Oncology …, 2020 - jglobal.jst.go.jp
Ng M Fleming T Robinson M Thomson B Graetz N Margono C. Global, regional, and
national prevalence of overweight and obesity in children and adults during 1980-2013: a …
national prevalence of overweight and obesity in children and adults during 1980-2013: a …
Obesity, Type 2 Diabetes, and Cancer Risk.
T Scully, A Ettela, D LeRoith, EJ Gallagher - Frontiers in Oncology, 2020 - europepmc.org
Obesity and type 2 diabetes have both been associated with increased cancer risk and are
becoming increasingly prevalent. Metabolic abnormalities such as insulin resistance and …
becoming increasingly prevalent. Metabolic abnormalities such as insulin resistance and …
Obesity, Type 2 Diabetes, and Cancer Risk
T Scully, A Ettela, D LeRoith… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Obesity and type 2 diabetes have both been associated with increased cancer risk and are
becoming increasingly prevalent. Metabolic abnormalities such as insulin resistance and …
becoming increasingly prevalent. Metabolic abnormalities such as insulin resistance and …